Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Duffy MJ (2017) Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM. Eur J Cancer 75:284–298
Lamerz R (2012) CA 15-3. In: Thomas L (Hrsg) Labor und Diagnose, 8. Aufl. TH-Books, Frankfurt am Main, S 1644–1648
Stieber P et al (2015) Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer-A retrospective analysis of kinetics on 743 breast cancer patients. Clin Chim Acta 448:228–231
Sturgeon CM, Duffy MJ, Stenman UH et al (2008) National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem 54:e11–e79
Trapé J et al (2011) Increased plasma concentrations of tumour markers in the absence of neoplasia. Clin Chem Lab Med 49:1605–1620
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Holdenrieder, S., Stieber, P. (2019). Carbohydrate antigen 15-3. In: Gressner, A.M., Arndt, T. (eds) Lexikon der Medizinischen Laboratoriumsdiagnostik. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48986-4_662
Download citation
DOI: https://doi.org/10.1007/978-3-662-48986-4_662
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-48985-7
Online ISBN: 978-3-662-48986-4
eBook Packages: Medicine (German Language)